1. Home
  2. DNOW vs NVCR Comparison

DNOW vs NVCR Comparison

Compare DNOW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • NVCR
  • Stock Information
  • Founded
  • DNOW 1862
  • NVCR 2000
  • Country
  • DNOW United States
  • NVCR Switzerland
  • Employees
  • DNOW N/A
  • NVCR N/A
  • Industry
  • DNOW Metal Fabrications
  • NVCR Medical/Dental Instruments
  • Sector
  • DNOW Industrials
  • NVCR Health Care
  • Exchange
  • DNOW Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • DNOW 1.8B
  • NVCR 1.9B
  • IPO Year
  • DNOW N/A
  • NVCR 2015
  • Fundamental
  • Price
  • DNOW $14.34
  • NVCR $17.74
  • Analyst Decision
  • DNOW Buy
  • NVCR Buy
  • Analyst Count
  • DNOW 2
  • NVCR 6
  • Target Price
  • DNOW $18.50
  • NVCR $32.83
  • AVG Volume (30 Days)
  • DNOW 1.1M
  • NVCR 1.6M
  • Earning Date
  • DNOW 08-06-2025
  • NVCR 07-24-2025
  • Dividend Yield
  • DNOW N/A
  • NVCR N/A
  • EPS Growth
  • DNOW N/A
  • NVCR N/A
  • EPS
  • DNOW 0.75
  • NVCR N/A
  • Revenue
  • DNOW $2,409,000,000.00
  • NVCR $621,711,000.00
  • Revenue This Year
  • DNOW $4.72
  • NVCR $5.56
  • Revenue Next Year
  • DNOW $4.27
  • NVCR $9.19
  • P/E Ratio
  • DNOW $19.05
  • NVCR N/A
  • Revenue Growth
  • DNOW 4.74
  • NVCR 18.27
  • 52 Week Low
  • DNOW $11.42
  • NVCR $14.17
  • 52 Week High
  • DNOW $18.45
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 42.91
  • NVCR 51.60
  • Support Level
  • DNOW $14.12
  • NVCR $17.53
  • Resistance Level
  • DNOW $16.62
  • NVCR $18.70
  • Average True Range (ATR)
  • DNOW 0.52
  • NVCR 0.71
  • MACD
  • DNOW -0.07
  • NVCR 0.09
  • Stochastic Oscillator
  • DNOW 8.80
  • NVCR 61.75

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: